Christina C Westhoff1, Janice Mrozinski2,3, Ina Riedel2,4, Hans W Heid5, Roland Moll2. 1. Institute of Pathology, Philipps University of Marburg and University Hospital Giessen and Marburg, Baldingerstrasse, 35043, Marburg, Germany. westhoff@med.uni-marburg.de. 2. Institute of Pathology, Philipps University of Marburg and University Hospital Giessen and Marburg, Baldingerstrasse, 35043, Marburg, Germany. 3. MVZ Bad Salzungen, Ruhla, Germany. 4. Institute of Pathology, Municipal Hospital Dresden-Friedrichstadt, Dresden, Germany. 5. Helmholtz Group for Cell Biology, German Cancer Research Center, Heidelberg, Germany.
Abstract
PURPOSE: Liposarcomas are the most common soft tissue sarcomas of adults. The identification of lipoblastic cells in soft tissue sarcomas is mandatory for the diagnosis of most subtypes of liposarcomas but may be difficult in conventional histology. The present study focuses on the expression and possible diagnostic impact of two PAT family proteins, perilipin 1/perilipin and perilipin 2/adipophilin in human liposarcomas. METHODS: Eighty-seven cases of liposarcomas and 30 cases of non-lipomatous sarcomas were investigated immunohistochemically for perilipin 1 and 2 using entire tissue sections. Statistical analyses were performed using appropriate tests. RESULTS: Most liposarcomas and non-lipomatous sarcomas displayed positivity for perilipin 2. In contrast, while more than two-thirds of liposarcomas presented perilipin 1 positivity, all non-lipomatous sarcomas studied were negative for this marker, with statistical significance (p < 0.001). Perilipin 1 expression increased with adipocytic differentiation of liposarcoma subtypes showing statistical significance (p < 0.001). Non-lipomatous sarcomas demonstrated variable expression levels of perilipin 2. The expression level of perilipin 2 appeared to be correlated with tumor cell degeneration, e.g., through hypoxia. CONCLUSIONS: Perilipin 2 is not well suitable for distinction between liposarcomas and non-lipomatous sarcomas. However, perilipin 1 appeared to be a highly specific marker for liposarcoma and adipocytic differentiation in sarcomas with intermediate sensitivity.
PURPOSE:Liposarcomas are the most common soft tissue sarcomas of adults. The identification of lipoblastic cells in soft tissue sarcomas is mandatory for the diagnosis of most subtypes of liposarcomas but may be difficult in conventional histology. The present study focuses on the expression and possible diagnostic impact of two PAT family proteins, perilipin 1/perilipin and perilipin 2/adipophilin in humanliposarcomas. METHODS: Eighty-seven cases of liposarcomas and 30 cases of non-lipomatous sarcomas were investigated immunohistochemically for perilipin 1 and 2 using entire tissue sections. Statistical analyses were performed using appropriate tests. RESULTS: Most liposarcomas and non-lipomatous sarcomas displayed positivity for perilipin 2. In contrast, while more than two-thirds of liposarcomas presented perilipin 1 positivity, all non-lipomatous sarcomas studied were negative for this marker, with statistical significance (p < 0.001). Perilipin 1 expression increased with adipocytic differentiation of liposarcoma subtypes showing statistical significance (p < 0.001). Non-lipomatous sarcomas demonstrated variable expression levels of perilipin 2. The expression level of perilipin 2 appeared to be correlated with tumor cell degeneration, e.g., through hypoxia. CONCLUSIONS:Perilipin 2 is not well suitable for distinction between liposarcomas and non-lipomatous sarcomas. However, perilipin 1 appeared to be a highly specific marker for liposarcoma and adipocytic differentiation in sarcomas with intermediate sensitivity.
Entities:
Keywords:
Adipophilin; Degeneration; Differential expression; Hypoxia; Liposarcoma; PAT family protein; Perilipin 1; Perilipin 2; Soft tissue sarcoma
Authors: Arne M Olsen; Burton L Eisenberg; Nancy B Kuemmerle; Alison J Flanagan; Peter M Morganelli; Portia S Lombardo; Johannes V Swinnen; William B Kinlaw Journal: Int J Oncol Date: 2010-05 Impact factor: 5.650
Authors: Beate Katharina Straub; Benedek Gyoengyoesi; Maria Koenig; Merita Hashani; Lena Maria Pawella; Esther Herpel; Wolf Mueller; Stephan Macher-Goeppinger; Hans Heid; Peter Schirmacher Journal: Histopathology Date: 2013-01-24 Impact factor: 5.087
Authors: Lena Maria Pawella; Merita Hashani; Eva Eiteneuer; Marcus Renner; Ralf Bartenschlager; Peter Schirmacher; Beate Katharina Straub Journal: J Hepatol Date: 2013-11-19 Impact factor: 25.083